GLP-1 Telehealth Providers: Price Terms and Program Questions
This page compares advertised program terms and current quote questions for five GLP-1 telehealth providers. Pricing and availability can change; the table separates dated provider statements from details that remain unverified.
GLP-1 Provider Quotes and Terms
The table is a checklist for comparing a quote for a specific medication and prescribed dose. Confirm what the listed figure includes, when billing renews, and any fees or cancellation terms.
| Feature | SurpassMD | TrimRx | Fridays | Henry Meds | Remedy Meds |
|---|---|---|---|---|---|
| Semaglutide (monthly) | Promo from $114/mo; eligible patients; request full terms | Current quote not verified; request terms | Current medication quote not verified | Current medication quote not verified | Current medication quote not verified |
| Payment and renewal terms | Confirm payment period and renewal total | Current prepay and renewal terms unverified | Four-month promotion; confirm renewal terms | Site describes monthly billing; confirm terms | Current payment and renewal terms unverified |
| Tirzepatide (monthly) | Promo from $177/mo; eligible patients; request full terms | Current quote not verified; request terms | Request quote for exact current product | Current medication quote not verified | Current medication quote not verified |
| Oral option | Site lists oral semaglutide; clinician decides | Confirm formulation and current availability | Confirm formulation and current availability | Confirm formulation and current availability | Confirm formulation and current availability |
| Medication and dose price terms | Flat pricing across doses for each medication | Current dose-dependent terms unverified | Current dose-dependent terms unverified | Current dose-dependent terms unverified | Current dose-dependent terms unverified |
| Shipping | Site says within 48 hours after approval | Request dispatch and delivery terms | Request dispatch and delivery terms | Request dispatch and delivery terms | Request dispatch and delivery terms |
| Nutrition and support scope | Confirm nutrition services included in quote | Confirm consultation and support scope | Site lists dietitians; confirm plan scope | Confirm consultation and support scope | Confirm messaging and clinician-check-in terms |
| Insurance help (brand meds) | Cash-pay; ask about beneficiary restrictions | Confirm insurer and payment terms | Site describes insurance help; confirm scope | Confirm insurer and payment terms | Confirm insurer and payment terms |
| Coverage | Site lists 50 states + DC; services vary | Current service area not verified | Confirm current service area and eligibility | Confirm current service area and eligibility | Confirm current service area and eligibility |
Provider website statements are dated self-reports, not independent tests of price, delivery, or clinical outcomes. The exact preparation and prescribing decision matter.
SurpassMD: Advertised Price Terms and Care Questions
On October 12, 2026, SurpassMD’s website advertised promotional starting prices for eligible patients, subject to provider approval; the offer has flat pricing across doses for each medication. Other table entries are dated site statements or questions for the provider.
For program details, read our full SurpassMD review.
Questions: Which medication offer applies, and what payment, renewal, and cancellation terms are in writing?
TrimRx: Current Quote Needed
Direct review of TrimRx’s named domain did not produce a usable current quote. Medication prices, dose terms, payment cycle, current product availability, and service area remain unverified here. Request an itemized quote identifying medication, prescribed dose, fees, renewal, cancellation, and dispensing pharmacy.
Questions: Which current written quote and renewal terms apply? See our full TrimRx review.
Fridays: Program and Membership Terms
On October 27, 2026, Fridays’ site described a four-month membership promotion with a 25% discount that renews at the then-current discounted rate, subject to clinical eligibility. It describes dietitian access and help with insurance paperwork for brand-name medication; confirm whether those services and any fee apply to the selected plan.
Questions: What does the membership cover, how does its renewal work, and what current medication quote applies? The provider’s promotion terms distinguish membership billing from a guaranteed prescription. See our full Fridays review.
Henry Meds: Product and Billing Questions
On October 12, 2026, Henry Meds’ website described monthly billing with provider review and medication and supplies included. This page did not verify a fixed semaglutide or tirzepatide quote, a particular dose, or current product availability. Request the total recurring price and the terms for the exact medication and prescription.
Questions: Which medication and dose are currently offered, what is the full recurring price, and what review applies? See our full Henry Meds review.
Remedy Meds: Claims, Terms and Dated FDA Context
On October 12, 2026, Remedy Meds’ website marketed compounded GLP-1 programs; its clinical claims are not outcome evidence. FDA’s September 9, 2025 letter describes an August 2025 website review and objects to implications that compounded semaglutide or tirzepatide was the same as an approved drug. This dated letter does not establish current status or resolution.
Questions: What current product, price, billing, and clinician-review terms apply? See our full Remedy Meds review.
How to Choose a GLP-1 Telehealth Provider
Before enrolling, request the complete recurring cost for the exact medication and prescribed dose, renewal and cancellation rules, dispensing pharmacy, and expected dispatch and delivery terms. Ask which entity evaluates the prescription and what regulatory basis applies to the specific preparation; 503A and 503B settings are not interchangeable labels for identical oversight.
For deeper pricing context, see our guides to compounded semaglutide cost, compounded tirzepatide cost, and the full GLP-1 telehealth price comparison. For head-to-head matchups, see SurpassMD vs Henry Meds, SurpassMD vs TrimRx, SurpassMD vs Fridays, and SurpassMD vs Remedy Meds.
Verify current program details directly with the provider and prescribing clinician before submitting an intake. Published service-area, product, payment, and shipping statements can change and do not establish personal eligibility or fulfillment. Our GLP-1 Program Guide provides a framework to compare online care programs and included support.
Peptide Dossier and SurpassMD share ownership. We receive no referral fee or commission. Ownership disclosure.
Frequently Asked Questions
The available pages do not support a verified cheapest-provider ranking. Compare an itemized quote for the exact medication and prescribed dose, payment and renewal period, fees, and cancellation terms; advertised starting figures are not complete comparable quotes.
This comparison cannot determine eligibility or guarantee a prescription. Ask each provider how its intake and independent clinical review work, which pharmacy would dispense, and what the specific program includes.
Compounded drugs are not FDA-approved. A compounded preparation is not an FDA-approved generic version of a branded drug.
The pages reviewed do not establish one insurance rule across providers. Ask whether the specific program bills your plan, whether any help is limited to paperwork for brand-name medication, and what you would owe if coverage is denied.
The available information does not establish which provider delivers fastest. Request the dispatch cutoff and carrier estimate, and distinguish a dispatch target from the date medication arrives.
Ask both prescribing clinicians how they will review your records and whether a new prescription is appropriate. Do not change medication or dose based on a vendor comparison; confirm continuity and timing directly with your clinician.
A prescription is not guaranteed. Ask the evaluating provider what follow-up or other options are appropriate for your circumstances; eligibility and clinical decisions belong to that provider.
Cayman lists retatrutide for research use in its catalog; its product says it is not for human or veterinary use. These examples do not establish every peptide or vendor.
FDA says compounded drugs are not FDA-approved or reviewed before marketing for safety, effectiveness, or quality. FDA describes separate 503A and 503B frameworks; verify the entity and preparation that would dispense.